{"gene":"TG_291040","gene_symbol":"LDH2","run_date":"2026-09-08T14:08:30","timeline":{"discoveries":[{"year":1997,"finding":"LDH2 gene encodes a lactate dehydrogenase homolog with 71.1% amino acid identity to LDH1; LDH2 mRNA is exclusively detected in the bradyzoite stage, while LDH1 mRNA is detected in both tachyzoites and bradyzoites. A reporter construct carrying the LDH2 promoter sequence was significantly upregulated under alkaline pH (pH 8.2, bradyzoite-inducing conditions), demonstrating that LDH2 expression is transcriptionally regulated in a stage-specific manner.","method":"Northern blot/RT-PCR for mRNA detection, isoelectric focusing and immunoblot for protein isoform analysis, chloramphenicol acetyltransferase (CAT) reporter gene assay with LDH2 promoter under alkaline pH conditions","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (mRNA analysis, protein isoform analysis, and functional promoter reporter assay) in a single focused study establishing transcriptional regulation","pmids":["9016946"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2001,"finding":"Recombinant LDH1 and LDH2 from T. gondii were characterized kinetically: both exhibit broader substrate specificity than Plasmodium falciparum LDH (pLDH); LDH2 utilizes 3-phenylpyruvate as a better substrate than pyruvate; both LDH1 and LDH2 efficiently use the NAD analog APAD; LDH2 (unlike LDH1) does not exhibit substrate inhibition despite having an identical M163 residue at the cofactor binding site. Both isoforms are competitively inhibited by gossypol and derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids.","method":"In vitro enzyme kinetic assays with recombinant proteins, substrate specificity testing, inhibitor dose-response assays, tachyzoite growth inhibition in fibroblast cultures","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic reconstitution with multiple substrates and inhibitors tested on purified recombinant proteins","pmids":["11704270"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2002,"finding":"LDH2 protein is exclusively expressed in the cytoplasm of bradyzoites (not in tachyzoites or coccidian stages), as determined by immunocytochemistry and immunoelectron microscopy. The isoenzyme switch from LDH1 to LDH2 occurs at an early stage of tachyzoite-to-bradyzoite conversion when bradyzoites are actively proliferating.","method":"Immunocytochemistry and immunoelectron microscopy in vivo (mouse lung and brain tissue, cat intestine), using stage-specific antibodies","journal":"International journal for parasitology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular localization by immunoelectron microscopy replicated across multiple life stages and host tissues","pmids":["12350375"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2004,"finding":"Knockdown of LDH2 (and LDH1) expression in stable transgenic parasites impaired tachyzoite and bradyzoite differentiation in vitro and severely reduced tissue cyst formation in a murine model. LDH expression is required for parasite differentiation and establishment of chronic infection.","method":"Stable antisense/RNAi knockdown transgenic lines, in vitro differentiation assays, in vivo murine infection model measuring brain cyst burden","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined phenotypic readouts (differentiation, cyst formation) in both in vitro and in vivo settings, single lab","pmids":["15459194"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2009,"finding":"Over-expression of TgLDH2 (or TgLDH1) in tachyzoites did not affect enzymatic activity, growth, or virulence under standard conditions, but enhanced bradyzoite differentiation (increased cyst structure formation in vitro) under alkaline conditions, suggesting TgLDH2 has a physiological role in differentiation beyond glycolytic metabolism.","method":"Clonal transgenic parasite lines over-expressing TgLDH2, in vitro cyst formation assay under alkaline pH, growth and virulence assays","journal":"Experimental parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional over-expression in clonal lines with defined differentiation phenotype, single lab, single method","pmids":["19422070"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2015,"finding":"Unspliced (intron-retained) forms of LDH2 transcripts are produced during tachyzoite-to-bradyzoite stage transition, suggesting an intron retention mechanism contributes to rapid exchange of LDH isoforms during developmental adaptation.","method":"RT-PCR detection of unspliced transcript isoforms during stage transition, identification of regulatory elements in LDH transcription units","journal":"Molecular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct identification of intron-retained transcripts during stage conversion with characterization of regulatory elements, single lab","pmids":["25777509"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2017,"finding":"Deletion of LDH2 alone impaired chronic-stage cyst burdens in vivo without affecting acute virulence or bradyzoite differentiation in vitro. Deletion of both LDH1 and LDH2 caused more severe defects in cyst formation. The double-knockout (Δldh1 Δldh2) replicated more slowly under physiological oxygen levels (3%) and was more susceptible to the oxidative phosphorylation inhibitor oligomycin A, indicating LDH2 contributes to lactate fermentation that supplements energy production when oxygen is limited.","method":"CRISPR/Cas9 gene knockout of LDH2 alone and in combination with LDH1, in vitro growth assays under physiological O2, murine infection model measuring cyst burden, oligomycin A sensitivity assays","journal":"Cellular microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockouts with multiple orthogonal readouts (in vitro growth, in vivo cyst burden, pharmacological sensitivity), independently corroborated by a second study (PMID:28323833)","pmids":["29028143"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]},{"year":2017,"finding":"Deletion of LDH2 alone (Δldh2) impaired chronic-stage cyst burdens in vivo without affecting acute virulence or in vitro bradyzoite differentiation, whereas deletion of LDH1 reduced both acute virulence and bradyzoite differentiation. Combined deletion of LDH1 and LDH2 induced more severe defects in chronic cyst formation, but no growth defect was observed for any single or double mutant.","method":"Gene deletion by homologous recombination, in vitro bradyzoite differentiation assays, murine acute and chronic infection models, plaque assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockouts replicated across single and double mutants with multiple defined phenotypic readouts, corroborated by independent study (PMID:29028143)","pmids":["28323833"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2011,"finding":"TgRSC8, a subunit of an ATP-dependent chromatin remodeling complex (RSC/SWI-SNF ortholog), controls LDH2 transcript levels. In the C9 insertional mutant with reduced TgRSC8, steady-state LDH2 mRNA levels were significantly decreased; restoration of TgRSC8 expression by complementation significantly increased LDH2 transcript levels.","method":"Insertional mutagenesis, western blot and flow cytometry for TgRSC8 levels, quantitative PCR for LDH2 transcript, complementation rescue","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with complementation rescue, two orthogonal methods (qPCR and complementation), single lab","pmids":["21655329"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"current_model":"Toxoplasma gondii LDH2 is a bradyzoite-specific cytoplasmic lactate dehydrogenase whose expression is transcriptionally upregulated via its promoter during stage conversion; it catalyzes lactate fermentation with broad substrate specificity (preferring 3-phenylpyruvate over pyruvate), supplements energy production under physiological (low-oxygen) conditions, contributes to chronic-stage cyst formation in vivo, and its stage-specific expression is regulated through both promoter-level transcriptional control (modulated by chromatin remodeling via TgRSC8) and post-transcriptional intron retention during stage transition."},"narrative":{"mechanistic_narrative":"Toxoplasma gondii LDH2 is a bradyzoite-specific lactate dehydrogenase that supports the parasite's metabolic and developmental transition to the chronic cyst stage [PMID:9016946, PMID:29028143]. It arose as a homolog of the constitutive tachyzoite enzyme LDH1 (71.1% identity), but its mRNA and cytoplasmic protein are restricted to the bradyzoite stage, with the LDH1-to-LDH2 isoenzyme switch occurring early during tachyzoite-to-bradyzoite conversion [PMID:9016946, PMID:12350375]. As an enzyme, recombinant LDH2 displays broad substrate specificity, preferring 3-phenylpyruvate over pyruvate, efficiently using the NAD analog APAD, and — unlike LDH1 — lacking substrate inhibition; it is competitively inhibited by gossypol derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids [PMID:11704270]. Functionally, LDH2 contributes to lactate fermentation that supplements energy production under physiological low-oxygen conditions, and its loss impairs chronic-stage cyst formation in vivo [PMID:29028143]. Stage-specific expression is controlled at multiple levels: the LDH2 promoter is transcriptionally upregulated under bradyzoite-inducing alkaline conditions [PMID:9016946], its transcript abundance depends on the ATP-dependent chromatin-remodeling subunit TgRSC8 [PMID:21655329], and intron retention generates unspliced LDH2 transcripts during the stage transition [PMID:25777509].","teleology":[{"year":1997,"claim":"Establishing that T. gondii encodes a second LDH isoform answered whether the parasite deploys distinct metabolic enzymes across its life cycle, revealing LDH2 as a bradyzoite-restricted, transcriptionally stage-regulated gene.","evidence":"Northern blot/RT-PCR, isoelectric focusing/immunoblot isoform analysis, and CAT reporter assay with the LDH2 promoter under alkaline pH","pmids":["9016946"],"confidence":"High","gaps":["Does not identify the transcription factors binding the promoter","Does not establish the enzyme's catalytic properties"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2001,"claim":"Kinetic characterization of purified recombinant LDH2 answered how its enzymology differs from LDH1 and from Plasmodium LDH, defining its substrate preference and inhibitor sensitivity.","evidence":"In vitro enzyme kinetics with recombinant proteins, substrate/inhibitor dose-response assays, and tachyzoite growth inhibition in fibroblasts","pmids":["11704270"],"confidence":"High","gaps":["Physiological relevance of 3-phenylpyruvate preference in vivo unclear","Does not link enzymatic activity to a cellular phenotype"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2002,"claim":"Direct subcellular and stage-resolved localization answered where and when LDH2 is expressed, showing it is cytoplasmic and appears at the onset of bradyzoite conversion.","evidence":"Immunocytochemistry and immunoelectron microscopy in mouse lung/brain and cat intestine with stage-specific antibodies","pmids":["12350375"],"confidence":"High","gaps":["Does not address the functional consequence of the isoenzyme switch","Timing of switch not tied to specific molecular triggers"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2004,"claim":"Knockdown of LDH addressed whether the enzyme is required for the developmental program, showing LDH expression is needed for differentiation and chronic infection.","evidence":"Stable antisense/RNAi knockdown lines, in vitro differentiation assays, and murine brain cyst burden measurement","pmids":["15459194"],"confidence":"Medium","gaps":["Knockdown cannot separate LDH2-specific from LDH1 contributions","Residual expression may obscure full loss-of-function phenotype"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2009,"claim":"Over-expression addressed whether LDH2 actively promotes differentiation, showing excess LDH2 enhances cyst formation under alkaline conditions, implying a role beyond baseline glycolysis.","evidence":"Clonal over-expression lines, in vitro cyst formation assay under alkaline pH, and growth/virulence assays","pmids":["19422070"],"confidence":"Medium","gaps":["Single lab, single differentiation readout","Mechanism linking LDH2 abundance to differentiation not defined"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2011,"claim":"Identifying TgRSC8 as a controller of LDH2 transcript levels answered how chromatin remodeling contributes to LDH2 regulation, adding an epigenetic layer to its stage-specific control.","evidence":"Insertional mutagenesis, qPCR for LDH2 transcript, and complementation rescue of TgRSC8","pmids":["21655329"],"confidence":"Medium","gaps":["Does not show direct RSC8 occupancy at the LDH2 locus","Effect may be indirect within the broader chromatin program"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2015,"claim":"Detection of intron-retained LDH2 transcripts answered how isoform exchange is achieved rapidly, introducing post-transcriptional intron retention as a regulatory mechanism during stage transition.","evidence":"RT-PCR detection of unspliced transcript isoforms and characterization of regulatory elements in LDH transcription units","pmids":["25777509"],"confidence":"Medium","gaps":["Functional consequence of retained introns on protein output not quantified","Splicing factors mediating retention unidentified"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2017,"claim":"Clean CRISPR and homologous-recombination knockouts resolved the specific role of LDH2 versus LDH1, showing LDH2 loss impairs chronic cyst burden and lactate fermentation supports energy production under low oxygen, with double deletion producing more severe defects.","evidence":"CRISPR/Cas9 and homologous-recombination knockouts (single and double), in vitro growth under 3% O2, murine cyst burden, and oligomycin A sensitivity assays","pmids":["29028143","28323833"],"confidence":"High","gaps":["Precise metabolic flux through LDH2 not directly measured","How lactate fermentation integrates with mitochondrial metabolism unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"},{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":null,"claim":"The molecular link between LDH2's enzymatic activity and its requirement for cyst formation — whether lactate metabolism per se or a moonlighting differentiation function drives the phenotype — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No catalytically dead LDH2 rescue experiment reported","Metabolic dependency of chronic-stage bradyzoites on LDH2 flux not directly quantified"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":[],"other_free_text":["Bradyzoite-specific isoform; LDH1-to-LDH2 isoenzyme switch occurs early in tachyzoite-to-bradyzoite conversion [#0, #2]","Substrate preference for 3-phenylpyruvate over pyruvate; efficient use of NAD analog APAD; lacks substrate inhibition seen in LDH1 despite identical M163 cofactor-binding residue [#1]","Competitively inhibited by gossypol derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids [#1]","Transcript levels controlled by the ATP-dependent chromatin-remodeling subunit TgRSC8 (RSC/SWI-SNF ortholog) [#8]","Regulated by intron retention generating unspliced transcripts during stage transition [#5]","Promoter upregulated under bradyzoite-inducing alkaline pH conditions [#0]"]},"strain_conflicts":[]},"prefetch_data":{},"corpus_meta":[{"pmid":"15003495","id":"PMC_15003495","title":"Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host.","date":"2004","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/15003495","citation_count":118,"is_preprint":false},{"pmid":"9016946","id":"PMC_9016946","title":"Toxoplasma gondii expresses two distinct lactate dehydrogenase homologous genes during its life cycle in intermediate hosts.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9016946","citation_count":111,"is_preprint":false},{"pmid":"12350375","id":"PMC_12350375","title":"Evidence for nuclear localisation of two stage-specific isoenzymes of enolase in Toxoplasma gondii correlates with active parasite replication.","date":"2002","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12350375","citation_count":67,"is_preprint":false},{"pmid":"14998514","id":"PMC_14998514","title":"The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection.","date":"2004","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/14998514","citation_count":66,"is_preprint":false},{"pmid":"11704270","id":"PMC_11704270","title":"The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum.","date":"2001","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11704270","citation_count":57,"is_preprint":false},{"pmid":"11254623","id":"PMC_11254623","title":"Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6.","date":"2001","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11254623","citation_count":56,"is_preprint":false},{"pmid":"29028143","id":"PMC_29028143","title":"Functional analysis of Toxoplasma lactate dehydrogenases suggests critical roles of lactate fermentation for parasite growth in vivo.","date":"2017","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29028143","citation_count":52,"is_preprint":false},{"pmid":"9274873","id":"PMC_9274873","title":"Stage-specific expression of a selectable marker in Toxoplasma gondii permits selective inhibition of either tachyzoites or bradyzoites.","date":"1997","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/9274873","citation_count":50,"is_preprint":false},{"pmid":"15459194","id":"PMC_15459194","title":"The expression of lactate dehydrogenase is important for the cell cycle of Toxoplasma gondii.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15459194","citation_count":48,"is_preprint":false},{"pmid":"28323833","id":"PMC_28323833","title":"Lactate dehydrogenase in Toxoplasma gondii controls virulence, bradyzoite differentiation, and chronic infection.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28323833","citation_count":46,"is_preprint":false},{"pmid":"30147689","id":"PMC_30147689","title":"A Lactate Fermentation Mutant of Toxoplasma Stimulates Protective Immunity Against Acute and Chronic Toxoplasmosis.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30147689","citation_count":42,"is_preprint":false},{"pmid":"25777509","id":"PMC_25777509","title":"Expression of the glycolytic enzymes enolase and lactate dehydrogenase during the early phase of Toxoplasma differentiation is regulated by an intron retention mechanism.","date":"2015","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25777509","citation_count":24,"is_preprint":false},{"pmid":"25300561","id":"PMC_25300561","title":"The optimal mixture of Toxoplasma gondii recombinant antigens (GRA1, P22, ROP1) for diagnosis of ovine toxoplasmosis.","date":"2014","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25300561","citation_count":20,"is_preprint":false},{"pmid":"26432517","id":"PMC_26432517","title":"Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo.","date":"2015","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/26432517","citation_count":19,"is_preprint":false},{"pmid":"21655329","id":"PMC_21655329","title":"Involvement of a Toxoplasma gondii chromatin remodeling complex ortholog in developmental regulation.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21655329","citation_count":12,"is_preprint":false},{"pmid":"11580972","id":"PMC_11580972","title":"Tachyzoite-specific isoform of Toxoplasma gondii lactate dehydrogenase is the target antigen of a murine CD4(+) T-cell clone.","date":"2001","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/11580972","citation_count":12,"is_preprint":false},{"pmid":"37832712","id":"PMC_37832712","title":"A newly characterized dense granule protein (GRA76) is important for the growth and virulence of Toxoplasma gondii.","date":"2023","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/37832712","citation_count":11,"is_preprint":false},{"pmid":"39150246","id":"PMC_39150246","title":"Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii.","date":"2024","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/39150246","citation_count":10,"is_preprint":false},{"pmid":"11719953","id":"PMC_11719953","title":"Construction and validation of a polycompetitor construct (SWITCH) for use in competitive RT-PCR to assess tachyzoite-bradyzoite interconversion in Toxoplasma gondii.","date":"2001","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11719953","citation_count":10,"is_preprint":false},{"pmid":"35735977","id":"PMC_35735977","title":"Nuclear Factor AP2X-4 Governs the Expression of Cell Cycle- and Life Stage-Regulated Genes and is Critical for Toxoplasma Growth.","date":"2022","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/35735977","citation_count":8,"is_preprint":false},{"pmid":"38673969","id":"PMC_38673969","title":"The Development of Toxoplasma gondii Recombinant Trivalent Chimeric Proteins as an Alternative to Toxoplasma Lysate Antigen (TLA) in Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Immunoglobulin G (IgG) in Small Ruminants.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38673969","citation_count":8,"is_preprint":false},{"pmid":"19422070","id":"PMC_19422070","title":"Toxoplasma gondii: over-expression of lactate dehydrogenase enhances differentiation under alkaline conditions.","date":"2009","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/19422070","citation_count":8,"is_preprint":false},{"pmid":"32468190","id":"PMC_32468190","title":"Toxoplasma gondii metacaspase 2 is an important factor that influences bradyzoite formation in the Pru strain.","date":"2020","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/32468190","citation_count":3,"is_preprint":false},{"pmid":"38464000","id":"PMC_38464000","title":"Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38464000","citation_count":2,"is_preprint":false},{"pmid":"40244171","id":"PMC_40244171","title":"Role of Toxoplasma gondii p24δ in Regulating the Transition from Tachyzoite to Bradyzoite Development.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40244171","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16012,"output_tokens":2770,"usd":0.044793,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8492,"output_tokens":3649,"usd":0.066842,"stage2_stop_reason":"end_turn"},"total_usd":0.111635,"stage1_batch_id":"msgbatch_015xmQKDRqnTh9anE4m7LiD6","stage2_batch_id":"msgbatch_01JLpkFTVhoQBNgqHCKFrVVU","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"LDH2 gene encodes a lactate dehydrogenase homolog with 71.1% amino acid identity to LDH1; LDH2 mRNA is exclusively detected in the bradyzoite stage, while LDH1 mRNA is detected in both tachyzoites and bradyzoites. A reporter construct carrying the LDH2 promoter sequence was significantly upregulated under alkaline pH (pH 8.2, bradyzoite-inducing conditions), demonstrating that LDH2 expression is transcriptionally regulated in a stage-specific manner.\",\n      \"method\": \"Northern blot/RT-PCR for mRNA detection, isoelectric focusing and immunoblot for protein isoform analysis, chloramphenicol acetyltransferase (CAT) reporter gene assay with LDH2 promoter under alkaline pH conditions\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (mRNA analysis, protein isoform analysis, and functional promoter reporter assay) in a single focused study establishing transcriptional regulation\",\n      \"pmids\": [\"9016946\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Recombinant LDH1 and LDH2 from T. gondii were characterized kinetically: both exhibit broader substrate specificity than Plasmodium falciparum LDH (pLDH); LDH2 utilizes 3-phenylpyruvate as a better substrate than pyruvate; both LDH1 and LDH2 efficiently use the NAD analog APAD; LDH2 (unlike LDH1) does not exhibit substrate inhibition despite having an identical M163 residue at the cofactor binding site. Both isoforms are competitively inhibited by gossypol and derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids.\",\n      \"method\": \"In vitro enzyme kinetic assays with recombinant proteins, substrate specificity testing, inhibitor dose-response assays, tachyzoite growth inhibition in fibroblast cultures\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic reconstitution with multiple substrates and inhibitors tested on purified recombinant proteins\",\n      \"pmids\": [\"11704270\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"LDH2 protein is exclusively expressed in the cytoplasm of bradyzoites (not in tachyzoites or coccidian stages), as determined by immunocytochemistry and immunoelectron microscopy. The isoenzyme switch from LDH1 to LDH2 occurs at an early stage of tachyzoite-to-bradyzoite conversion when bradyzoites are actively proliferating.\",\n      \"method\": \"Immunocytochemistry and immunoelectron microscopy in vivo (mouse lung and brain tissue, cat intestine), using stage-specific antibodies\",\n      \"journal\": \"International journal for parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular localization by immunoelectron microscopy replicated across multiple life stages and host tissues\",\n      \"pmids\": [\"12350375\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Knockdown of LDH2 (and LDH1) expression in stable transgenic parasites impaired tachyzoite and bradyzoite differentiation in vitro and severely reduced tissue cyst formation in a murine model. LDH expression is required for parasite differentiation and establishment of chronic infection.\",\n      \"method\": \"Stable antisense/RNAi knockdown transgenic lines, in vitro differentiation assays, in vivo murine infection model measuring brain cyst burden\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined phenotypic readouts (differentiation, cyst formation) in both in vitro and in vivo settings, single lab\",\n      \"pmids\": [\"15459194\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Over-expression of TgLDH2 (or TgLDH1) in tachyzoites did not affect enzymatic activity, growth, or virulence under standard conditions, but enhanced bradyzoite differentiation (increased cyst structure formation in vitro) under alkaline conditions, suggesting TgLDH2 has a physiological role in differentiation beyond glycolytic metabolism.\",\n      \"method\": \"Clonal transgenic parasite lines over-expressing TgLDH2, in vitro cyst formation assay under alkaline pH, growth and virulence assays\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional over-expression in clonal lines with defined differentiation phenotype, single lab, single method\",\n      \"pmids\": [\"19422070\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Unspliced (intron-retained) forms of LDH2 transcripts are produced during tachyzoite-to-bradyzoite stage transition, suggesting an intron retention mechanism contributes to rapid exchange of LDH isoforms during developmental adaptation.\",\n      \"method\": \"RT-PCR detection of unspliced transcript isoforms during stage transition, identification of regulatory elements in LDH transcription units\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct identification of intron-retained transcripts during stage conversion with characterization of regulatory elements, single lab\",\n      \"pmids\": [\"25777509\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Deletion of LDH2 alone impaired chronic-stage cyst burdens in vivo without affecting acute virulence or bradyzoite differentiation in vitro. Deletion of both LDH1 and LDH2 caused more severe defects in cyst formation. The double-knockout (Δldh1 Δldh2) replicated more slowly under physiological oxygen levels (3%) and was more susceptible to the oxidative phosphorylation inhibitor oligomycin A, indicating LDH2 contributes to lactate fermentation that supplements energy production when oxygen is limited.\",\n      \"method\": \"CRISPR/Cas9 gene knockout of LDH2 alone and in combination with LDH1, in vitro growth assays under physiological O2, murine infection model measuring cyst burden, oligomycin A sensitivity assays\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockouts with multiple orthogonal readouts (in vitro growth, in vivo cyst burden, pharmacological sensitivity), independently corroborated by a second study (PMID:28323833)\",\n      \"pmids\": [\"29028143\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Deletion of LDH2 alone (Δldh2) impaired chronic-stage cyst burdens in vivo without affecting acute virulence or in vitro bradyzoite differentiation, whereas deletion of LDH1 reduced both acute virulence and bradyzoite differentiation. Combined deletion of LDH1 and LDH2 induced more severe defects in chronic cyst formation, but no growth defect was observed for any single or double mutant.\",\n      \"method\": \"Gene deletion by homologous recombination, in vitro bradyzoite differentiation assays, murine acute and chronic infection models, plaque assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockouts replicated across single and double mutants with multiple defined phenotypic readouts, corroborated by independent study (PMID:29028143)\",\n      \"pmids\": [\"28323833\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TgRSC8, a subunit of an ATP-dependent chromatin remodeling complex (RSC/SWI-SNF ortholog), controls LDH2 transcript levels. In the C9 insertional mutant with reduced TgRSC8, steady-state LDH2 mRNA levels were significantly decreased; restoration of TgRSC8 expression by complementation significantly increased LDH2 transcript levels.\",\n      \"method\": \"Insertional mutagenesis, western blot and flow cytometry for TgRSC8 levels, quantitative PCR for LDH2 transcript, complementation rescue\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with complementation rescue, two orthogonal methods (qPCR and complementation), single lab\",\n      \"pmids\": [\"21655329\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"Toxoplasma gondii LDH2 is a bradyzoite-specific cytoplasmic lactate dehydrogenase whose expression is transcriptionally upregulated via its promoter during stage conversion; it catalyzes lactate fermentation with broad substrate specificity (preferring 3-phenylpyruvate over pyruvate), supplements energy production under physiological (low-oxygen) conditions, contributes to chronic-stage cyst formation in vivo, and its stage-specific expression is regulated through both promoter-level transcriptional control (modulated by chromatin remodeling via TgRSC8) and post-transcriptional intron retention during stage transition.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Toxoplasma gondii LDH2 is a bradyzoite-specific lactate dehydrogenase that supports the parasite's metabolic and developmental transition to the chronic cyst stage [#0, #6]. It arose as a homolog of the constitutive tachyzoite enzyme LDH1 (71.1% identity), but its mRNA and cytoplasmic protein are restricted to the bradyzoite stage, with the LDH1-to-LDH2 isoenzyme switch occurring early during tachyzoite-to-bradyzoite conversion [#0, #2]. As an enzyme, recombinant LDH2 displays broad substrate specificity, preferring 3-phenylpyruvate over pyruvate, efficiently using the NAD analog APAD, and — unlike LDH1 — lacking substrate inhibition; it is competitively inhibited by gossypol derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids [#1]. Functionally, LDH2 contributes to lactate fermentation that supplements energy production under physiological low-oxygen conditions, and its loss impairs chronic-stage cyst formation in vivo [#6]. Stage-specific expression is controlled at multiple levels: the LDH2 promoter is transcriptionally upregulated under bradyzoite-inducing alkaline conditions [#0], its transcript abundance depends on the ATP-dependent chromatin-remodeling subunit TgRSC8 [#8], and intron retention generates unspliced LDH2 transcripts during the stage transition [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that T. gondii encodes a second LDH isoform answered whether the parasite deploys distinct metabolic enzymes across its life cycle, revealing LDH2 as a bradyzoite-restricted, transcriptionally stage-regulated gene.\",\n      \"evidence\": \"Northern blot/RT-PCR, isoelectric focusing/immunoblot isoform analysis, and CAT reporter assay with the LDH2 promoter under alkaline pH\",\n      \"pmids\": [\"9016946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not identify the transcription factors binding the promoter\", \"Does not establish the enzyme's catalytic properties\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Kinetic characterization of purified recombinant LDH2 answered how its enzymology differs from LDH1 and from Plasmodium LDH, defining its substrate preference and inhibitor sensitivity.\",\n      \"evidence\": \"In vitro enzyme kinetics with recombinant proteins, substrate/inhibitor dose-response assays, and tachyzoite growth inhibition in fibroblasts\",\n      \"pmids\": [\"11704270\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of 3-phenylpyruvate preference in vivo unclear\", \"Does not link enzymatic activity to a cellular phenotype\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Direct subcellular and stage-resolved localization answered where and when LDH2 is expressed, showing it is cytoplasmic and appears at the onset of bradyzoite conversion.\",\n      \"evidence\": \"Immunocytochemistry and immunoelectron microscopy in mouse lung/brain and cat intestine with stage-specific antibodies\",\n      \"pmids\": [\"12350375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address the functional consequence of the isoenzyme switch\", \"Timing of switch not tied to specific molecular triggers\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Knockdown of LDH addressed whether the enzyme is required for the developmental program, showing LDH expression is needed for differentiation and chronic infection.\",\n      \"evidence\": \"Stable antisense/RNAi knockdown lines, in vitro differentiation assays, and murine brain cyst burden measurement\",\n      \"pmids\": [\"15459194\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Knockdown cannot separate LDH2-specific from LDH1 contributions\", \"Residual expression may obscure full loss-of-function phenotype\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Over-expression addressed whether LDH2 actively promotes differentiation, showing excess LDH2 enhances cyst formation under alkaline conditions, implying a role beyond baseline glycolysis.\",\n      \"evidence\": \"Clonal over-expression lines, in vitro cyst formation assay under alkaline pH, and growth/virulence assays\",\n      \"pmids\": [\"19422070\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, single differentiation readout\", \"Mechanism linking LDH2 abundance to differentiation not defined\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying TgRSC8 as a controller of LDH2 transcript levels answered how chromatin remodeling contributes to LDH2 regulation, adding an epigenetic layer to its stage-specific control.\",\n      \"evidence\": \"Insertional mutagenesis, qPCR for LDH2 transcript, and complementation rescue of TgRSC8\",\n      \"pmids\": [\"21655329\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not show direct RSC8 occupancy at the LDH2 locus\", \"Effect may be indirect within the broader chromatin program\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Detection of intron-retained LDH2 transcripts answered how isoform exchange is achieved rapidly, introducing post-transcriptional intron retention as a regulatory mechanism during stage transition.\",\n      \"evidence\": \"RT-PCR detection of unspliced transcript isoforms and characterization of regulatory elements in LDH transcription units\",\n      \"pmids\": [\"25777509\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of retained introns on protein output not quantified\", \"Splicing factors mediating retention unidentified\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Clean CRISPR and homologous-recombination knockouts resolved the specific role of LDH2 versus LDH1, showing LDH2 loss impairs chronic cyst burden and lactate fermentation supports energy production under low oxygen, with double deletion producing more severe defects.\",\n      \"evidence\": \"CRISPR/Cas9 and homologous-recombination knockouts (single and double), in vitro growth under 3% O2, murine cyst burden, and oligomycin A sensitivity assays\",\n      \"pmids\": [\"29028143\", \"28323833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise metabolic flux through LDH2 not directly measured\", \"How lactate fermentation integrates with mitochondrial metabolism unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}, {\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular link between LDH2's enzymatic activity and its requirement for cyst formation — whether lactate metabolism per se or a moonlighting differentiation function drives the phenotype — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No catalytically dead LDH2 rescue experiment reported\", \"Metabolic dependency of chronic-stage bradyzoites on LDH2 flux not directly quantified\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004459\", \"supporting_discovery_ids\": [1], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0019661\", \"supporting_discovery_ids\": [6], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005737\", \"supporting_discovery_ids\": [2], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0006090\", \"supporting_discovery_ids\": [6], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]},\n      {\"term_id\": \"GO:0030587\", \"supporting_discovery_ids\": [3, 6, 7], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": [\n      \"Bradyzoite-specific isoform; LDH1-to-LDH2 isoenzyme switch occurs early in tachyzoite-to-bradyzoite conversion [#0, #2]\",\n      \"Substrate preference for 3-phenylpyruvate over pyruvate; efficient use of NAD analog APAD; lacks substrate inhibition seen in LDH1 despite identical M163 cofactor-binding residue [#1]\",\n      \"Competitively inhibited by gossypol derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids [#1]\",\n      \"Transcript levels controlled by the ATP-dependent chromatin-remodeling subunit TgRSC8 (RSC/SWI-SNF ortholog) [#8]\",\n      \"Regulated by intron retention generating unspliced transcripts during stage transition [#5]\",\n      \"Promoter upregulated under bradyzoite-inducing alkaline pH conditions [#0]\"\n    ]\n  },\n  \"strain_conflicts\": []\n}\n```","audit_flag":null,"strains":[{"strain":"ME49","gene_id":"TGME49_291040","name":"LDH2","product":"lactate dehydrogenase LDH2","uniprot_acc":"A0A125YPI5","chromosome":"TGME49_chrIX","start_pos":4081173},{"strain":"GT1","gene_id":"TGGT1_291040","name":null,"product":"lactate dehydrogenase LDH2","uniprot_acc":null,"chromosome":"TGGT1_chrIX","start_pos":3890037},{"strain":"RH88","gene_id":"TGRH88_015400","name":null,"product":"lactate dehydrogenase LDH2","uniprot_acc":null,"chromosome":"CM023090","start_pos":4146070},{"strain":"VEG","gene_id":"TGVEG_291040","name":null,"product":"lactate dehydrogenase LDH2","uniprot_acc":"B9PTD9","chromosome":"TGVEG_chrIX","start_pos":4116819}]}